Completed PHASE2 INTERVENTIONAL 2-arm NCT00489866

Aripiprazole Augmentation of Antidepressants in PTSD

Sponsor: Durham VA Medical Center

Conditions PTSD

Updated 8 times since 2017 Last updated: Mar 12, 2015 Started: Mar 31, 2007 Primary completion: Sep 30, 2008 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00489866, this PHASE2 trial focuses on PTSD and remains completed. Sponsored by Durham VA Medical Center, it has been updated 8 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE2
Dec 2021 — Dec 2022 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Jan 2021 — Dec 2021 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Mar 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Durham VA Medical Center

Data source: Durham VA Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Durham, United States